January 27, 2026 at 1PM EST

The pharmaceutical landscape is rapidly evolving with a diverse array of new products. This contemporary webinar provides a deep dive into how payers are reacting to novel market entrants across seven distinct product archetypes (including Specialty, Biosimilars, Digital Therapeutics, and CGT). Attendees will gain actionable insights through: 

• Archetype-Specific Coverage Trends: Detailed analysis of payer responses to new FDA approvals (from 2024 through 1H 2025) and indications across all major product categories. 

• Clinical Innovation & Access Strategy: Discussion on how therapeutic area dynamics and launch activity are directly shaping successful access strategies. 

• Payer Behavior Case Studies: Lessons from recent successful and challenging launches, illustrating how to optimize market entries based on product archetype. 

• 2026 New Market Entrant Outlook: Brief discussion on anticipated 2026 entrants and analysis across product archetype 

Kerri Fortier
Principal Consultant, Blue Fin Group

Jonathan Clark
Senior Consultant, Blue Fin Group